Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Trustmark National Bank Trust Department

Trustmark National Bank Trust Department reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 1.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 26,439 shares of the company’s stock after selling 430 shares during the period. Trustmark National Bank Trust Department’s holdings in Henry Schein were worth $2,144,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Cambridge Investment Research Advisors Inc. increased its holdings in shares of Henry Schein by 2.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company’s stock valued at $459,000 after purchasing an additional 122 shares during the period. HighTower Advisors LLC lifted its stake in Henry Schein by 18.9% in the 1st quarter. HighTower Advisors LLC now owns 14,030 shares of the company’s stock worth $1,220,000 after acquiring an additional 2,226 shares in the last quarter. MetLife Investment Management LLC lifted its stake in Henry Schein by 23.2% in the 1st quarter. MetLife Investment Management LLC now owns 37,733 shares of the company’s stock worth $3,290,000 after acquiring an additional 7,095 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in Henry Schein by 6.6% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 18,555 shares of the company’s stock worth $1,618,000 after acquiring an additional 1,149 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Henry Schein by 4.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,300,357 shares of the company’s stock worth $113,386,000 after acquiring an additional 51,106 shares in the last quarter. 93.31% of the stock is owned by institutional investors and hedge funds.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $68.75 on Friday. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $89.72. The firm has a market capitalization of $8.98 billion, a PE ratio of 20.46, a PEG ratio of 2.45 and a beta of 0.87. The business’s 50 day moving average is $70.18 and its 200-day moving average is $74.99. The company has a current ratio of 1.72, a quick ratio of 0.91 and a debt-to-equity ratio of 0.27.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Monday, November 13th. The company reported $1.32 earnings per share for the quarter, hitting the consensus estimate of $1.32. Henry Schein had a return on equity of 16.22% and a net margin of 3.51%. The company had revenue of $3.16 billion for the quarter, compared to analyst estimates of $3.21 billion. During the same quarter last year, the firm earned $1.15 EPS. Henry Schein’s revenue for the quarter was up 3.1% compared to the same quarter last year. Sell-side analysts predict that Henry Schein, Inc. will post 4.62 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. JPMorgan Chase & Co. increased their price objective on Henry Schein from $80.00 to $83.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 9th. Stifel Nicolaus raised Henry Schein from a “hold” rating to a “buy” rating and set a $70.00 price target for the company in a research note on Friday, November 10th. Morgan Stanley cut their price objective on Henry Schein from $69.00 to $65.00 and set an “underweight” rating on the stock in a research note on Tuesday. TheStreet downgraded Henry Schein from a “b-” rating to a “c+” rating in a research note on Thursday, November 2nd. Finally, Credit Suisse Group reissued an “outperform” rating and issued a $96.00 price objective on shares of Henry Schein in a research note on Tuesday, August 8th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $78.75.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.